LOVELAND, Colo., April 27, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, will be presenting at the following upcoming conferences:
- May 3-4, 2017 - Deutsche Bank 42nd Annual Healthcare Conference at the InterContinental Boston Hotel, Boston, Mass. Kevin Wilson, Heska's President & Chief Executive Officer, will be available for one-on-one meetings.
- May 24-25, 2017 - B. Riley & Co. 18th Annual Institutional Investor Conference at the Loews Santa Monica Beach Hotel, Santa Monica, Calif. John McMahon, Heska's Chief Financial Officer, will be available on May 24th for one-on-one meetings.
- May 31, 2017 – Stifel 2017 Dental & Veterinary Conference at the Peninsula Hotel, New York, NY. Mr. McMahon will be presenting in a Fireside Chat at 12:05 p.m. (Eastern) in the Gramercy Room and will be available for one-on-one meetings. The audio of the Company's group presentation will be available at http://wsw.com/webcast/stifel9/hska and the webcast will be archived for 90 days following the live presentation.
- June 1, 2017 - Benchmark Company, LLC One-on-One Conference at Palmer House Hilton in Chicago, Ill. Mr. Wilson will be available for one-on-one meetings.
For more information regarding these conferences, please contact Brett Maas at Hayden IR.
Heska Corporation (NASDAQ:HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.
SOURCE Heska Corporation